| Literature DB >> 20529376 |
Ada Tang1, Susan Marzolini, Paul Oh, William E McIlroy, Dina Brooks.
Abstract
BACKGROUND: Despite the cardiovascular etiology of stroke, exercise and risk factor modification programs akin to cardiac rehabilitation (CR) are not available. This study aimed to establish the feasibility of adapting a CR model for individuals with mild to moderate stroke disability. A secondary objective was to determine the program's effects on aerobic and walking capacity, and stroke risk factors.Entities:
Mesh:
Year: 2010 PMID: 20529376 PMCID: PMC2892442 DOI: 10.1186/1471-2377-10-40
Source DB: PubMed Journal: BMC Neurol ISSN: 1471-2377 Impact factor: 2.474
Figure 1Study design. Schematic of time points for data collection and overall study design
Figure 2Participant flow chart. Flow of participants through the study
Participant characteristics
| Variable | n (%) or mean ± SD (range) |
|---|---|
| Men | 30 (70%) |
| Age, years | 64.5 ± 12.2 (38-86) |
| Time post-stroke, months | 30 ± 27.3 (3-113) |
| Ischemic/Hemorrhagic/Unknown stroke type | 27 (63%)/11 (26%)/5 (12%) |
| Right/Left/Bilateral hemisphere affected | 17 (40%)/24 (56%)/2 (5%) |
| Cardiovascular history | |
| Prior stroke/transient ischemic attack | 5 (12%)/2 (5%) |
| Atrial fibrillation | 7 (16%) |
| Myocardial infarction | 1 (2%) |
| Left ventricular hypertrophy | 1 (2%) |
| Coronary artery bypass graft surgery | 4 (9%) |
| Percutaneous coronary intervention | 1 (2%) |
| Diabetes | 12 (28%) |
| Hypertension | 28 (65%) |
| Dyslipidemia | 34 (79%) |
| Never smoked/Remote smoker/Currently smoking | 29 (67%)/9 (21%)/5 (12%) |
| Gait aids, None/Cane/Walker/Rollator | 17 (40%)/18 (42%)/1 (2%)/7 (16%) |
| National Institutes of Health stroke scale score | 2.9 ± 2.7 (0-11) |
| Chedoke-McMaster Stroke Assessment scores | |
| Arm/Hand | 4.4 ± 1.6 (2-7)/4.6 ± 1.8 (2-7) |
| Leg/Foot | 5.1 ± 1.3 (2-7)/4.4 ± 1.7 (2-7) |
| Berg Balance Scale score | 46.4 ± 11.6 (4-56) |
| 5-Meter Walk | |
| Self-paced gait speed, cm/s | 76.8 ± 35.5 (20.4-152.3) |
| Fast-paced gait speed, cm/s | 85.2 ± 37.4 (28.3-169.7) |
| Calculated gait symmetry ratio, self-paced walk | 1.50 ± 0.6 (1.01-3.85) |
| Calculated gait symmetry ratio, fast-paced walk | 1.49 ± 0.49 (1.02-2.63) |
Baseline characteristics for all participants, n = 43
Changes in study outcomes measured across 3 time points
| n | Pre-Baseline -3 months | Pre-Program 0 months | Post-Program 6 months | ANOVA contrast for Pre-Baseline (-3 months) vs. Pre-Program (0 months) | ANOVA contrast for Baseline Period (-3, 0 months) vs. Post-Program (6 months) | |
|---|---|---|---|---|---|---|
| VO2peak, ml·kg-1·min-1 | 32 | 13.6 ± 4.1 | 14.8 ± 4.8 | 16.2 ± 5.1 | 0.301 | 0.046 |
| Peak workload, watts | 36 | 60.4 ± 27.8 | 63.1 ± 31.2 | 64.6 ± 33.2 | 0.709 | 0.647 |
| Ventilatory anaerobic threshold, ml·kg-1·min-1 | 27 | 10.3 ± 2.7 | 11 ± 3.2 | 11.9 ± 3.0 | 0.335 | 0.062 |
| Resting heart rate, beats/minute | 38 | 73.9 ± 13.8 | 73.4 ± 12.5 | 71.6 ± 14.8 | 0.877 | 0.459 |
| Resting blood pressure | ||||||
| Systolic, mmHg | 38 | 121 ± 13.7 | 122.6 ± 15.7 | 122.8 ± 17.3 | 0.66 | 0.74 |
| Diastolic, mmHg | 38 | 76.4 ± 11.4 | 74.8 ± 10.9 | 77.3 ± 10 | 0.51 | 0.431 |
| 6MWT distance, meters | 37 | 284.2 ± 145.8 | 286.4 ± 140 | 311 ± 152.1 | 0.948 | 0.382 |
Changes in study outcomes across 3 time points: pre-baseline (-3 months), and pre- and post-program (0, 6 months)
Values are mean ± SD (range). Abbreviations: 6MWT = 6-Minute Walk Test; SIS = Stroke Impact Scale.
Figure 3Changes in aerobic capacity and walking function. Changes in A) VO2peak and B) 6-minute walk distance pre-baseline (-3 months), and pre- and post-program (0, 6 months). Error bars indicate standard deviation.
Changes in study outcomes measured at 2 time points
| n | Pre-Program 0 months | Post-Program 6 months | ||
|---|---|---|---|---|
| Waist circumference, centimeters | 34 | 97.5 ± 15.5 (70-126) | 97.2 ± 13.4 (74-125) | 0.72 |
| Hip circumference, centimeters | 34 | 103.9 ± 10.4 (79-126) | 103.6 ± 9.8 (81-126) | 0.59 |
| Waist-hip ratio | 34 | 0.94 ± 0.1 (0.77-1.26) | 0.94 ± 0.1 (0.78-1.08) | 0.88 |
| Body fat, % | 32 | 28.1 ± 8.7 (9.7-47) | 27.8 ± 8.6 (10.3-49.7) | 0.27 |
| LDL cholesterol, mmol/L | 27 | 2.38 ± 0.7 (1.3-3.8) | 2.38 ± 0.7 (1.2-3.7) | 0.48 |
| HDL cholesterol, mmol/L | 27 | 1.27 ± 0.3 (0.78-1.83) | 1.31 ± 0.3 (0.91-2.0) | 0.96 |
| Total-HDL cholesterol ratio | 27 | 3.84 ± 0.8 (2.1-5.6) | 3.76 ± 1.0 (2.2-5.7) | 0.60 |
| Triglycerides | 27 | 1.34 ± 0.8 (0.5-4.2) | 1.37 ± 0.7 (0.4-3.2) | 0.26 |
| Blood glucose, mmol/L | 28 | 5.79 ± 1.1 (4.4-9.4) | 5.55 ± 1.0 (4-8) | 0.35 |
| Glycated hemoglobin, % | 28 | 5.88 ± 0.7 (4.8-8.2) | 5.94 ± 0.7 (4.9-7.5) | 0.71 |
| 26 | 10 (39%) | 8 (31%) | 0.18 |
Changes in study outcomes across 2 time points: pre-program (0 months) to post-program (6 months)
Values are n (%) or mean ± SD (range). Abbreviations: HDL = high-density lipoprotein; LDL = low-density lipoprotein.